Swedish Orphan Biovitrum (BIOVF) Stock Price, Quote, News & History

Swedish Orphan Biovitrum AB (BIOVF) Stock Price, Quote, News & History

BIOVFOTCPK

Trade with Public

$41.32

Last update: Mar 4, 10:49 AM

Key Statistics

Open

Volume / Avg.

0 / 304.00

Day Range

- - -

52 Wk Range

25.80 - 42.22

Market Cap

$14.24B

P/E Ratio

278.49

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Swedish Orphan Biovitrum AB (publ) News

Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants

Merck announces positive results from Phase 2b/3 and interim Phase 3 trials of a monoclonal antibody designed to protect infants from RSV.

Vandana Singh

Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases

Swedish Orphan Biovitrum and Apellis Pharmaceuticals released topline results from the Phase 3 VALIANT study of pegcetacoplan for C3 glomerulopathy and IC-MPGN. The study met primary and secondary endpoints, showing proteinuria and kidney inflammation reductions.

Vandana Singh

Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants

As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Abrysvo, to pregnant patients and Sanofi SA's (NASDAQ:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

8.57B

Investing Cash Flow (TTM)

-4.29B

Financing Cash Flow (TTM)

-4.32B

Free Cash Flow (TTM)

5.41B

Capital Expenditure (TTM)

-3.15B

Net Change in Cash (TTM)

-52.00M

Valuation Metrics

Enterprise Value

$15.12B

PE Ratio (TTM)

278.49

PE Ratio (FWD)

24.21

PEG Ratio (TTM)

0.35

PS Ratio (TTM)

4.70

PB Ratio (TTM)

3.50

Earnings Yield % (TTM)

0.36%

Earnings Yield % (FWD)

4.13%

EV / EBITDA (TTM)

7.99

Price / EBITDA (TTM)

7.55

Price / Free Cash Flow (TTM)

24.51

Book Value / Share

$11.82

Company Debt

Total Debt

$11.12B

LT Debt

$5.18B

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.04B

Debt to Equity

0.30

Issuance of Debt (TTM)

-$4.93B

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 304.00

Day Range

- - -

52 Wk Range

25.80 - 42.22

Market Cap

$14.24B

P/E Ratio

278.49

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 20...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Swedish Orphan Biovitrum (BIOVF) stock?

You can purchase shares of Swedish Orphan Biovitrum (OTCPK:BIOVF) through any online brokerage.

View our list of the best stock brokerages

Who are Swedish Orphan Biovitrum (BIOVF) competitors?

There are no as such competitors for Swedish Orphan Biovitrum.

What is the forecast, or price target, for Swedish Orphan Biovitrum (BIOVF) stock?

There is no analysis for Swedish Orphan Biovitrum to provide a consensus price target.

What is the current price for Swedish Orphan Biovitrum (BIOVF)?

The stock price for Swedish Orphan Biovitrum (OTCPK: BIOVF) is $41.32 last updated March 4, 2026 at 10:49 AM EST.

Does Swedish Orphan Biovitrum (BIOVF) pay a dividend?

There are no upcoming dividends for Swedish Orphan Biovitrum.

When is Swedish Orphan Biovitrum (OTCPK:BIOVF) reporting earnings?

Swedish Orphan Biovitrum does not have any upcoming earnings scheduled.

Is Swedish Orphan Biovitrum (BIOVF) going to split?

There is no upcoming split for Swedish Orphan Biovitrum.

What sector and industry does Swedish Orphan Biovitrum (BIOVF) operate in?

Swedish Orphan Biovitrum is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Key Statistics

Open

Volume / Avg.

0 / 304.00

Day Range

- - -

52 Wk Range

25.80 - 42.22

Market Cap

$14.24B

P/E Ratio

278.49

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Swedish Orphan Biovitrum AB (publ) News

Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants

Merck announces positive results from Phase 2b/3 and interim Phase 3 trials of a monoclonal antibody designed to protect infants from RSV.

Vandana Singh

Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases

Vandana Singh

Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants

As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Abrysvo, to pregnant patients and Sanofi SA's (NASDAQ:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

8.57B

Investing Cash Flow (TTM)

-4.29B

Financing Cash Flow (TTM)

-4.32B

Free Cash Flow (TTM)

5.41B

Capital Expenditure (TTM)

-3.15B

Net Change in Cash (TTM)

-52.00M

Valuation Metrics

Enterprise Value

$15.12B

PE Ratio (TTM)

278.49

PE Ratio (FWD)

24.21

PEG Ratio (TTM)

0.35

PS Ratio (TTM)

4.70

PB Ratio (TTM)

3.50

Earnings Yield % (TTM)

0.36%

Earnings Yield % (FWD)

4.13%

EV / EBITDA (TTM)

7.99

Price / EBITDA (TTM)

7.55

Price / Free Cash Flow (TTM)

24.51

Book Value / Share

$11.82

Company Debt

Total Debt

$11.12B

LT Debt

$5.18B

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.04B

Debt to Equity

0.30

Issuance of Debt (TTM)

-$4.93B

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 304.00

Day Range

- - -

52 Wk Range

25.80 - 42.22

Market Cap

$14.24B

P/E Ratio

278.49

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Swedish Orphan Biovitrum (BIOVF) stock?

You can purchase shares of Swedish Orphan Biovitrum (OTCPK:BIOVF) through any online brokerage.

View our list of the best stock brokerages

Who are Swedish Orphan Biovitrum (BIOVF) competitors?

There are no as such competitors for Swedish Orphan Biovitrum.

What is the forecast, or price target, for Swedish Orphan Biovitrum (BIOVF) stock?

There is no analysis for Swedish Orphan Biovitrum to provide a consensus price target.

What is the current price for Swedish Orphan Biovitrum (BIOVF)?

The stock price for Swedish Orphan Biovitrum (OTCPK: BIOVF) is $41.32 last updated March 4, 2026 at 10:49 AM EST.

Does Swedish Orphan Biovitrum (BIOVF) pay a dividend?

There are no upcoming dividends for Swedish Orphan Biovitrum.

When is Swedish Orphan Biovitrum (OTCPK:BIOVF) reporting earnings?

Swedish Orphan Biovitrum does not have any upcoming earnings scheduled.

Is Swedish Orphan Biovitrum (BIOVF) going to split?

There is no upcoming split for Swedish Orphan Biovitrum.

What sector and industry does Swedish Orphan Biovitrum (BIOVF) operate in?

Swedish Orphan Biovitrum is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.